Hospers GAP - Search Results

1

Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.

Visconti A, Rossi N, Deriš H, Lee KA, Hanić M, Trbojević-Akmačić I, Thomas AM, Bolte LA, Björk JR, Hooiveld-Noeken JS, Board R, Harland M, Newton-Bishop J, Harries M, Sacco JJ, Lorigan P, Shaw HM, de Vries EGE, Fehrmann RSN, Weersma RK, Spector TD, Nathan P, Hospers GAP, Sasieni P, Bataille V, Lauc G, Falchi M. Visconti A, et al. Among authors: hospers gap. BMC Cancer. 2023 Feb 18;23(1):166. doi: 10.1186/s12885-023-10511-3. BMC Cancer. 2023. PMID: 36805683 Free PMC article.

2

The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.

Hospers GA, de Vries EG, Mulder NH. Hospers GA, et al. Br J Cancer. 1990 Jan;61(1):79-82. doi: 10.1038/bjc.1990.18. Br J Cancer. 1990. PMID: 2153398 Free PMC article.

3

A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.

Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG. Hospers GA, et al. Int J Cancer. 1990 Jul 15;46(1):138-44. doi: 10.1002/ijc.2910460125. Int J Cancer. 1990. PMID: 2163989

4

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG. Meijer C, et al. Br J Cancer. 1990 Jul;62(1):72-7. doi: 10.1038/bjc.1990.232. Br J Cancer. 1990. PMID: 2390486 Free PMC article.

5

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.

Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG. Timmer-Bosscha H, et al. J Natl Cancer Inst. 1989 Jul 19;81(14):1069-75. doi: 10.1093/jnci/81.14.1069. J Natl Cancer Inst. 1989. PMID: 2544740

6

Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG. Hospers GA, et al. Cancer Res. 1988 Dec 1;48(23):6803-7. Cancer Res. 1988. PMID: 2846161

7

Mechanisms of cellular resistance to cisplatin.

Hospers GA, Mulder NH, De Vries EG. Hospers GA, et al. Med Oncol Tumor Pharmacother. 1988;5(3):145-51. doi: 10.1007/BF02986437. Med Oncol Tumor Pharmacother. 1988. PMID: 3045443 Review.

8

A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.

Hendrikse NH, de Vries EG, Eriks-Fluks L, van der Graaf WT, Hospers GA, Willemsen AT, Vaalburg W, Franssen EJ. Hendrikse NH, et al. Cancer Res. 1999 May 15;59(10):2411-6. Cancer Res. 1999. PMID: 10344751

9

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects.

Hospers GA, Eisenhauer EA, de Vries EG. Hospers GA, et al. Br J Cancer. 1999 May;80(5-6):629-38. doi: 10.1038/sj.bjc.6690404. Br J Cancer. 1999. PMID: 10360638 Free PMC article. Review.

10

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.

Schröder CP, de Vries EG, Mulder NH, Willemse PH, Sleijfer DT, Hospers GA, van der Graaf WT. Schröder CP, et al. J Antimicrob Chemother. 1999 May;43(5):741-3. doi: 10.1093/jac/43.5.741. J Antimicrob Chemother. 1999. PMID: 10382902 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page